The Chemours Company $CC Shares Bought by Legal & General Group Plc

Legal & General Group Plc grew its holdings in shares of The Chemours Company (NYSE:CC) by 19.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,139,617 shares of the specialty chemicals company’s stock after purchasing an additional 355,074 shares during the period. Legal & General Group Plc owned 1.43% of Chemours worth $25,226,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Baird Financial Group Inc. bought a new position in shares of Chemours during the first quarter worth about $148,000. Royal Bank of Canada raised its holdings in shares of Chemours by 6.8% during the first quarter. Royal Bank of Canada now owns 585,702 shares of the specialty chemicals company’s stock valued at $7,926,000 after buying an additional 37,382 shares during the last quarter. AQR Capital Management LLC acquired a new position in shares of Chemours during the first quarter worth approximately $161,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Chemours by 149.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 43,243 shares of the specialty chemicals company’s stock worth $593,000 after buying an additional 25,899 shares during the period. Finally, Empowered Funds LLC bought a new position in Chemours in the 1st quarter worth approximately $403,000. 76.26% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Weiss Ratings reissued a “sell (d)” rating on shares of Chemours in a report on Monday, April 20th. The Goldman Sachs Group upped their price target on shares of Chemours from $14.00 to $18.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 25th. BMO Capital Markets decreased their price objective on shares of Chemours from $20.00 to $19.00 and set an “outperform” rating for the company in a report on Monday, February 23rd. Truist Financial boosted their target price on Chemours from $27.00 to $30.00 and gave the stock a “buy” rating in a report on Tuesday, April 28th. Finally, Morgan Stanley increased their price target on Chemours from $17.00 to $21.00 and gave the company an “equal weight” rating in a research note on Monday, May 11th. Six investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Chemours currently has an average rating of “Hold” and an average target price of $24.60.

Chemours Stock Up 0.0%

Shares of Chemours stock opened at $22.17 on Monday. The Chemours Company has a 12-month low of $9.13 and a 12-month high of $28.67. The firm has a market capitalization of $3.33 billion, a PE ratio of -8.40 and a beta of 1.40. The company has a quick ratio of 0.87, a current ratio of 1.82 and a debt-to-equity ratio of 18.98. The stock’s fifty day moving average is $22.83 and its 200-day moving average is $17.72.

Chemours (NYSE:CC) last issued its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.10. Chemours had a positive return on equity of 52.49% and a negative net margin of 6.82%.The firm had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.40 billion. During the same quarter last year, the business posted $0.13 EPS. Chemours’s revenue was up 1.0% on a year-over-year basis. Equities analysts anticipate that The Chemours Company will post 1.27 earnings per share for the current year.

Chemours Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Sunday, May 17th will be given a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a yield of 1.6%. The ex-dividend date is Friday, May 15th. Chemours’s payout ratio is presently -13.26%.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.